Verition Fund Management’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,230
Closed -$13.1K 3433
2024
Q3
$13.1K Buy
+13,230
New +$18.2K ﹤0.01% 3090
2024
Q2
Sell
-30,000
Closed -$49.2K 3186
2024
Q1
$49.2K Sell
30,000
-370,000
-93% -$310K ﹤0.01% 2636
2023
Q4
$230K Hold
400,000
﹤0.01% 1944
2023
Q3
$160K Hold
400,000
﹤0.01% 2033
2023
Q2
$217K Buy
+400,000
New +$256K ﹤0.01% 1789
2023
Q1
Sell
-14,000
Closed -$18.2K 2442
2022
Q4
$18.2K Buy
+14,000
New +$21.8K ﹤0.01% 1930
2021
Q4
Sell
-21,402
Closed -$154K 2725
2021
Q3
$154K Buy
+21,402
New +$157K ﹤0.01% 1655

Other funds holding OCGN

Verition Fund Management's OCGN Position: Q4 2024 in Review

Verition Fund Management sold out of Ocugen (OCGN) in Q4 2024, closing a stake of 13,230 shares — an estimated $13.1K sold.

Verition Fund Management first reported a position in OCGN in Q3 2021 and held it in 7 quarters. The position peaked at $230K in Q4 2023. 114 funds tracked by Wall St. Rank hold OCGN as of Q4 2024.

  • Verition Fund Management reported no remaining Ocugen position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 13,230 Ocugen shares in Q4 2024, an estimated $13.1K.
  • Verition Fund Management first reported a position in Ocugen in Q3 2021 and held it in 7 quarters.
  • Verition Fund Management's Ocugen position peaked at $230K in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Ocugen as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.